NIBIB in the News

The podcast Epidemic, hosted by Dr. Celine Grounder and Robert Klain, featured episode 21: Are Antibodies the Holy Grail? Guests for this podcast episode are NIBIB's Kaitlyn Sadtler and NIAID's Matthew Memoli, who discuss the SARS-CoV-2 serology study they are conducting at NIH.

Listen and read a transcript.

A competition between researchers is part of a $1.5 billion program that seeks to speed development of accurate, quick and easy-to-use COVID-19 tests, NIH announced Wednesday.

Read HealthDay article at US News & World Report.

The National Institutes of Health is launching a new initiative to turbocharge innovation, development and commercialization of COVID-19 testing technologies as a way to help society get back to a place where restrictions can be lifted.

Read more at Fox News.

The National Institutes of Health on Wednesday announced a new $1.5 billion initiative to rapidly develop coronavirus diagnostics, an effort it says will result in the deployment of “millions of tests per week” by late summer or fall of this year.

Read more at STAT.

The U.S. National Institutes of Health (NIH) today announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for the virus that causes COVID-19. The program aims to increase the U.S. capacity for SARS-CoV-2 testing up to 100-fold by late summer, in time for the start of the flu season.

Read more at Science.

In this interview, David Zierler, Oral Historian for AIP, interviews Richard Leapman, Senior Investigator in the National Institute for Biomedical Imaging and Bioengineering and Scientific Director of the intramural program. Leapman recounts his childhood in England and he describes his early and formative experience playing with an optical microscope. Source: American Institute of Physics

Bruce Tromberg’s words drew murmurs of recognition from a crowd at the Photonics West conference in San Francisco, US, where he opened a packed Saturday afternoon of talks on entrepreneurship in healthcare photonics.

As the number of people suffering from Alzheimer’s disease (AD) and related dementias grows, so too does the pressure on the medical community to identify dementias as early as possible and potentially treat them. Researchers on both sides of the Atlantic are using optical technologies to capture the manifestations of dementia in the brain before outward symptoms of the condition occur.

Read more at Photonics.

When sparks fly to innovate new technologies for imaging life at the microscopic scale, often diverse researchers are nudging each other with a kind of collegial one-upmanship.

Multi-scale modeling in health and healthcare is a rapidly growing field. It uses computers and other technologies to address health-related issues and problems. Read more at Forbes